Why Africa’s push to make vaccines should look further than COVID-19
Africa’s segmented markets, and often small economies, are at odds with the fact that vaccines are mostly produced in large quantities to …
Nigeria at sixes and sevens on COVID-19 vaccine rollout
Nigeria plans to vaccinate 40% of its citizens before end of 2021 and 70% by end of 2022
Lateral Thoughts: A paradigm change in clinical trials
The rich and famous are clamouring to get the ‘experimental’ COVID-19 vaccine
COVID-19 shows why African data is key for the continent’s response to pandemics
African public health practitioners have amassed a wealth of experience of managing epidemics
Rwanda and Senegal will host Africa’s first COVID-19 vaccine plants: What’s known so far
Only Tunisia, Senegal, Egypt, Ethiopia, and South Africa have varying capabilities to produce and fill or finish vaccines
Low trust in authorities affects vaccine uptake: Evidence from 22 African countries
Nearly half of the world’s unvaccinated and under-vaccinated children live in Africa
Lateral Thoughts: Healthy ageing was never so attractive
Accessing COVID-19 vaccine is logistically difficult for the old and sick
COVID-19 vaccines work well with all body weights BUT underweight, obesity remain risk factors
A group of UK researchers compare how those vaccinated from across various categories fared against the novel coronavirus
Want to know about COVID-19 vaccine rollouts in Africa? Click on a country here and find out
In the 29 low-income countries, only 3 out of 100 people have received one dose of the vaccine
What are India’s options for a booster dose of COVID-19 vaccine
Hyderabad-based Biological E’s Corbevax and SII’s Covovax, both of which are protein-based vaccines, are India’s best bet for a …
Rich countries must share their vaccines with poor ones quickly: WHO panel
Vaccine distribution to low-income countries falls short of 1 billion target, former panel leaders, Ellen Johnson Sirleaf and Helen Clark, said
Back to school? May have unimaginable, uncontrollable consequences on health
Instead of reopening schools, educationists should research how to communicate efficiently in online classes
COVID-19 vaccination has turned into a ‘battle of the brands’. But not everyone’s buying it
The best thing we can do is to tone down the brand narrative within the significant constraints we face. All COVID-19 vaccines are safe and effective
Gujarat's pastoral communities struggling for awareness, infrastructure to combat second COVID-19 wave
The nomadic pastoral communities cannot afford to remain in their houses even during a pandemic
South African case study sheds light on how vaccine manufacturing can be developed
Additional costs made it harder for local companies to break even and recover working capital
Interested in vaccine rollouts across Africa? Here’s a map to guide you
A map that will be updated daily, showing how many people have been vaccinated across the continent
90% efficacy for Pfizer’s COVID-19 mRNA vaccine is striking. But we need to wait for the full data
Important questions remain: It’s unclear how long protection will last and if the vaccine protects against severe disease
What we know so far about COVID-19 vaccine: A comprehensive guide by academic experts
With so much at stake, it’s not surprising that COVID-19 vaccines have become a public and political obsession. The good news is that …
Is the COVID-19 vaccine story over?
India claims vaccines are no longer an issue in the battle against COVID-19, but a host of developing nations would disagree
COVID-19: It’s time to look at the finer details of South Africa’s pandemic picture
The current resurgence driven by the Delta variant finally appears to be subsiding in all nine provinces
Lateral thoughts: COVID-19 vaccines and a game of chance
Would you be compensated for adverse reactions to the COVID-19 vaccines?
Global COVID-19 death toll crosses 4 million
The total COVID-19 death toll is equivalent to number of people killed in all of world’s wars since 1982
Scientific innovation in 2021: Lessons from COVID-19
One of the bigger learnings of 2020 was that it takes time, planning, trust and bringing together of resources as well as knowledge to manage a …
Results from Novavax vaccine trials in the UK and South Africa differ: why, and does it matter?
The efficacy of the vaccine was 89 per cent in United Kingdom and 60 per cent in South Africa
Oxford COVID vaccine authorised in the UK – global health expert on why this is a key moment
To know the impact of the Oxford vaccine, we’ll have to wait and see. However, amid the intense doom and gloom of 2020, having multiple …